PNC Financial Services Group
MRVI icon

PNC Financial Services Group’s Maravai LifeSciences MRVI Stock Holding History

PNC Financial Services Group’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.9K Sell
12,485
-36
-0.3% -$155 ﹤0.01% 3084
2026
Q1 		$35.4K Buy
12,521
+35
+0.3% +$119 ﹤0.01% 3420
2025
Q4 		$40.6K Buy
12,486
+44
+0.4% +$148 ﹤0.01% 3328
2025
Q3 		$35.7K Buy
12,442
+697
+6% +$1.78K ﹤0.01% 3371
2025
Q2 		$28.3K Sell
11,745
-81
-0.7% -$170 ﹤0.01% 3406
2025
Q1 		$26.1K Buy
11,826
+604
+5% +$2.39K ﹤0.01% 3421
2024
Q4 		$61.2K Sell
11,222
-374
-3% -$2.41K ﹤0.01% 2976
2024
Q3 		$96.4K Sell
11,596
-225
-2% -$1.95K ﹤0.01% 2692
2024
Q2 		$84.6K Sell
11,821
-1,755
-13% -$15.2K ﹤0.01% 2725
2024
Q1 		$118K Buy
13,576
+3,073
+29% +$20.8K ﹤0.01% 2517
2023
Q4 		$68.8K Sell
10,503
-139
-1% -$898 ﹤0.01% 2805
2023
Q3 		$106K Buy
10,642
+1,380
+15% +$15.2K ﹤0.01% 2532
2023
Q2 		$115K Buy
9,262
+439
+5% +$5.92K ﹤0.01% 2560
2023
Q1 		$124K Buy
8,823
+1,621
+23% +$23.3K ﹤0.01% 2439
2022
Q4 		$103K Buy
7,202
+7,141
+11,707% +$112K ﹤0.01% 2545
2022
Q3 		$1K Sell
61
-11
-15% -$276 ﹤0.01% 4336
2022
Q2 		$3K Sell
72
-166
-70% -$5.26K ﹤0.01% 4120
2022
Q1 		$8K Buy
238
+144
+153% +$4.83K ﹤0.01% 3886
2021
Q4 		$4K Sell
94
-88
-48% -$3.56K ﹤0.01% 4026
2021
Q3 		$8K Buy
182
+55
+43% +$2.68K ﹤0.01% 3815
2021
Q2 		$5K Buy
+127
New +$4.92K ﹤0.01% 3885

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

PNC Financial Services Group's MRVI Position: Q2 2026 in Review

PNC Financial Services Group reduced its Maravai LifeSciences (MRVI) stake by 0.29% in Q2 2026, selling an estimated $155 and leaving 12,485 shares worth $77.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3084.

PNC Financial Services Group first reported a position in MRVI in Q2 2021 and has held it in 21 quarters since. The position peaked at $124K in Q1 2023. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • PNC Financial Services Group held 12,485 shares of Maravai LifeSciences worth $77.9K as of Q2 2026.
  • PNC Financial Services Group sold 36 Maravai LifeSciences shares in Q2 2026, an estimated $155.
  • Maravai LifeSciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3084 holding.
  • PNC Financial Services Group first reported a position in Maravai LifeSciences in Q2 2021 and has held it in 21 quarters since.
  • PNC Financial Services Group's Maravai LifeSciences position peaked at $124K in Q1 2023.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.